AZYO - Aziyo Biologics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
49,187
49,187
47,390
42,682
42,901
Cost of revenue
29,965
29,965
28,368
22,121
23,133
Gross profit
19,222
19,222
19,022
20,561
19,768
Operating expenses
Research development
8,940
8,940
9,266
4,083
2,400
Selling general and administrative
36,822
36,822
32,788
30,077
25,777
Total operating expenses
45,762
45,762
42,054
34,160
28,177
Operating income or loss
-26,540
-26,540
-23,032
-13,599
-8,409
Interest expense
5,282
5,282
5,324
5,633
5,381
Total other income/expenses net
-1,041
-1,041
3,579
-2,567
1,881
Income before tax
-32,863
-32,863
-24,777
-21,799
-11,909
Income tax expense
34
34
55
26
30
Income from continuing operations
-32,897
-32,897
-24,832
-21,825
-11,939
Net income
-32,897
-32,897
-24,832
-21,825
-11,939
Net income available to common shareholders
-32,897
-32,897
-24,832
-25,335
-11,941
Basic EPS
-
-2.38
-2.38
-8.88
-1.82
Diluted EPS
-
-2.38
-2.38
-8.88
-1.82
Basic average shares
-
13,833
10,445
2,853
6,578
Diluted average shares
-
13,833
10,445
2,853
6,578
EBITDA
-
-27,581
-19,453
-16,166
-2,672